Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.60 |
| ▸ | CA1 | P00915 | 1/20 | 0.60 |
| ▸ | CA2 | P00918 | 1/20 | 0.60 |
| ▸ | CA7 | P43166 | 1/20 | 0.60 |
| ▸ | CA9 | Q16790 | 1/20 | 0.60 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.60 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.47 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13176746 | 0.88 | CA12 (0.55) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10880498 | 0.85 | ABCG2 (0.53) | MEN1KMT2AMAPTABCG2KDM4E | |
| SCHEMBL8599970 | 0.83 | ABCG2 (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9297361 | 0.82 | ABCG2 (0.50) | NCEH1MEN1KMT2AMAPTABCG2 | |
| SCHEMBL71131 | 0.82 | NCEH1 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1648076 | 0.82 | NCEH1 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29404644 | 0.82 | NCEH1 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9193765 | 0.81 | NCEH1 (0.48) | NCEH1MEN1KMT2AMAPTABCG2 | |
| SCHEMBL28517298 | 0.81 | ABCG2 (0.49) | NCEH1MEN1KMT2AMAPTABCG2 | |
| SCHEMBL2217827 | 0.81 | ABCG2 (0.47) | NCEH1MEN1KMT2AMAPTABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559504-B2 | Benzotriazole derivative | UBE CORPORATION (JP) | 2026-02-24 | — | — | US | disclosed |
| EP-3978073-B1 | 1H-BENZO[D][1,2,3]TRIAZOLE DERIVATIVES AS KEAP1 INHIBITORS FOR THE TREATMENT OF RENAL DISEASES | UBE CORP (JP) | 2025-10-15 | — | — | EP | disclosed |
| CN-114174289-B | Benzotriazole derivatives | ＵＢＥ株式会社 | 2025-03-07 | — | — | CN | disclosed |
| US-12011432-B2 | Method of modulating ribonucleotide reductase | CASE WESTERN RESERVE UNIVERSITY (US) | 2024-06-18 | — | — | US | disclosed |
| CN-117651750-A | Ultraviolet absorber, method for producing same, composition, molded article, and coating film | 东洋油墨SC控股株式会社 | 2024-03-05 | — | — | CN | disclosed |
| WO-2023242454-A1 | HYBRID MATERIAL FOR DETECTING ACID AND BASE VAPOURS | UNIVERSIDAD DE CASTILLA LA MANCHA (ES) | 2023-12-21 | — | — | WO | disclosed |
| CN-117083263-A | Hydrazide compound, curable resin composition, sealant for liquid crystal display element, and liquid crystal display element | 积水化学工业株式会社 | 2023-11-17 | — | — | CN | disclosed |
| CN-114846085-B | Resin composition and molded article | 东洋油墨SC控股株式会社 | 2023-09-08 | — | — | CN | disclosed |
| WO-2023286725-A1 | UV ABSORBER AND MANUFACTURING METHOD THEREOF, COMPOSITION, MOLDED BODY AND COATING FILM | 東洋インキＳＣホールディングス株式会社 | 2023-01-19 | — | — | WO | disclosed |
| WO-2022270467-A1 | HYDRAZIDE COMPOUND, CURABLE RESIN COMPOSITION, SEALING AGENT FOR LIQUID CRYSTAL DISPLAY ELEMENTS, AND LIQUID CRYSTAL DISPLAY ELEMENT | 積水化学工業株式会社 | 2022-12-29 | — | — | WO | disclosed |
| US-5270730-A | Jet recording method and apparatus for discharging normally solid recording material by causing generated bubble to communicate with ambience | CANON KABUSHIKI KAISHA (JP) | 1993-12-14 | — | — | US | disclosed |
| EP-0256456-B1 | PIGMENT COMPOSITION | DAINICHISEIKA COLOR & CHEMICALS MFG. CO. LTD. (JP) | 1993-03-10 | — | — | EP | disclosed |
| EP-0256454-B1 | PIGMENT COMPOSITION | DAINICHISEIKA COLOR & CHEMICALS MFG. CO. LTD. (JP) | 1993-03-03 | — | — | EP | disclosed |
| EP-0479501-A2 | Jet recording method, normally solid recording material and recording apparatus for the method | CANON KABUSHIKI KAISHA (JP) | 1992-04-08 | — | — | EP | disclosed |
| US-4767465-A | POLYESTER DISPERSANT | DAINICHISEIKA COLOR & CHEMICALS MFG. CO., LTD. (JP) | 1988-08-30 | — | — | US | disclosed |
| US-4762568-A | PHOSPHORIC ESTER OF A POLYESTER AS DISPERSANT | DAINICHISEIKA COLOR & CHEMICALS MFG. CO., LTD. (JP) | 1988-08-09 | — | — | US | disclosed |
| EP-0256456-A2 | Pigment composition | DAINICHISEIKA COLOR & CHEMICALS MFG. CO. LTD. (JP) | 1988-02-24 | — | — | EP | disclosed |
| EP-0256454-A2 | Pigment composition | DAINICHISEIKA COLOR & CHEMICALS MFG. CO. LTD. (JP) | 1988-02-24 | — | — | EP | disclosed |
| US-4515849-A | Transfer printing sheet, printing method and printed article | MATSUI SHIKISO CHEMICAL CO. LTD. (JP) | 1985-05-07 | — | — | US | disclosed |
| US-4035512-A | Aminotetralols | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1977-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559504-B2 | Benzotriazole derivative | KEAP1, NFE2L2, NCOR1 | CA12 4658/4885CA1 4424/4885CA2 3070/4885 |
| US-12011432-B2 | Method of modulating ribonucleotide reductase | RRM2, RRM2B, RRM1 | CA12 2636/4885CA1 2716/4885CA2 2992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.